EBERS participated in the commercial exhibition of the European Society for Organ Transplantation (ESOT) congress that took place on September 15-18 in Copenhagen. The company showcased two units of the new normothermic organ preservation device in a stand and in a specific area of the venue exclusively dedicated to organ preservation technology. In addition, scientific results obtained with the system were presented in the scientific sessions.
 |
 |
The Spanish Association of Biocompanies (ASEBIO) organized in Madrid on the 26th of September an investor day, which put in contact international investors in the healthcare sector with Spanish companies. EBERS’ CEO, Pedro Moreo, participated in the event and held meetings with representatives of multiple venture capital funds, where he explained the progress of the project and the future commercialization and development plans for the company.
The normothermic preservation technology from EBERS was presented during the TERMIS-EU conference that took place on May 26-31 in Rhodes, Greece. The company was present with a stand in the commercial exhibition of the conference and, in addition, EBERS’ CEO presented participated with two posters in the scientific sessions of the conference.
 |
 |
 |
EBERS participated last July 9 in a seminar held in Beijing by our distributor in China, Cy-Tech. Our CEO, Pedro Moreo, talked about the advantages of normothermic perfusion applied to organs for transplantation and introduced the last results obtained with EBERS’ technology in animal models. Around one hundred people assisted to the meeting.
 |
 |
EBERS participated last May 24th in the HEALTH_LSR meeting that was held at the "Centro de Investigación Médica Avanzada" in Pamplona. Our CTO was talking about the advantages of normothermic perfusion applied to organs for transplantation. Around one hundred people assisted to the meeting, in which specialists of differen areas of engineering discussed about the application of innovative engineering techniques in medicine.
